LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by relevance 2,441 pages found matching data breach- Does New Warning For Ketek Go Far Enough?
Aug-8-07 Baltimore, MD At least four people have died and 37 others suffered liver damage after taking Ketek , an antibiotic made by Sanofi-Aventis. Now, many people are investigating the possibility of filing lawsuits after they suffered serious complications from taking the drug. The U.S. Food and Drug Administration (FDA) has responded by changing the labeling... - Saying 'No' to Avandia: Doctors are Taking no Chances
Aug-8-07 Eustis, FL While Avandia may still be viable for some patients in spite of possible increased risks for heart attack, stroke and kidney failure, most doctors are advocating a switch away from Avandia to an alternative drug therapy for their diabetic patients. While possible risk factors for the antidiabetic drug - made by GlaxoSmithKline - have been k... - Avandia Remains on Market Despite Health Risks
Aug-7-07 Los Angeles, CA: Despite expert testimony about its side effects risk, a Food and Drug Administration advisory committee has recommended that the diabetes drug Avandia should be allowed to stay on the market. But while the committee did not call for an Avandia recall, it says that the drug's label should carry a stronger warning about its risk of causing... - Iowa, USA TouchPlay Ban Settlement
Des Moines, IA: (Aug-06-07) Royal Financial, a West Des Moines company brought charges against the state following a legislature's decision to end TouchPlay gambling, a game resembling slot machines that has rapidly expanded across the state. Royal Financial was the largest individual owner of TouchPlay machines when lawmakers voted in March 2006 to outlaw... - Avandia: Did the FDA wait too long to act?
Aug-6-07 Washington, DC In the wake of a vote by a federal drug review committee to allow Avandia to remain on the market, the U.S Food and Drug Administration's (FDA) past positioning on the antidiabetic drug gives one pause to wonder why the agency hasn't seemed to have listened since 2000, when safety concerns about the potential dangers of Avandia first surfa... - Is Avandia Safe? Depends On Who You Talk To
Aug-5-07 Gaithersburg, MD When Dr. David Graham testified at the federal drug panel July 30th, reviewing the fate of diabetes drug Avandia and its alleged relationship to heart attack, stroke and kidney failure, he didn't mince words. "It's well established that rosiglitazone increases congestive heart failure," he said. The drug safety reviewer with the U.S... - Avandia Defended by Glaxo Despite Heart Attack Risk
Aug-2-07 Rockville, MD As part of the July 30th proceedings of a federal drug advisory committee that ultimately voted to keep Avandia on the market despite cardiovascular risk, Avandia maker GlaxoSmithKline defended its product as completely safe. Dr. Murray Stewart, A Vice President with the company, presented the findings of an examination of data from more... - Lawsuits Against Glaxo Rise as Avandia Sales Plummet
Aug-1-07 Washington, DC: A study released in July 2007, by the Federal Agency for Health Care Research and Quality, reported that the older diabetes drugs, available for as little as $10 a month, are as safe and effective as the newer drugs like Avandia (rosiglitazone), which costs between $131 and $262 a month. On July 20, 2007, Science Daily reported that li... - Avandia Allowed to Continue, Despite Risks
Jul-31-07 Gaithersburg, MD: Avandia , it seems, is back. In a remarkable turn of events, the diabetes drug that was vilified for cardiovascular risks only a few short months ago and made headlines around the world, was given a new lease on life by a federal drug advisory committee Monday. The vote to allow Avandia to remain on the market was described as 'overwh... - FDA Scientist Graham Calls Glaxo Avandia Trial Useless
Jul-30-07 Washington, DC: World-renowned cardiologist Dr Steven Nissen and statistician Kathy Wolski of the Cleveland Clinic posted a study online on May 21, 2007, to warn the public that the diabetes drug Avandia (rosiglitazone) increased the risk of heart attacks by 43% and the risk of death from cardiovascular causes by possibly 64%. A print edition of the s... - ReNu with MoistureLoc: Bausch & Lomb gets a Pass, but Hurdles Remain
Jul-30-07 Rochester, NY: In spite of its Greenville, South Carolina plant earning a pass after inspection by the FDA, Bausch & Lomb is still in the hot seat, facing more than 400 consumer lawsuits over its' recall last year of ReNu with MoistureLoc contact lens solution. The issue stems from a suspected link to Fusarium keratitus infection, which first surfaced... - Avandia Warnings might have prevented a Death
Jul-27-07 Dallas, TX Neil Pender's father passed away five years ago from a heart attack and he is angry. "My father started taking Avandia shortly after it was approved in 1999 but we didn't hear about the dangers of this drug until June of this year," says Pender. "My father, Roy, wasn't aware that he was a diabetic, but he did have high blood pressure," say... - University of Alaska Museum Construction Settlement
Fairbanks, AK: (Jul-22-07) Alaska Mechanical Inc. (AMI) brought a construction breach of contract claim against the University of Alaska, over the expansion of the Museum of the North in Fairbanks. The company filed a $17.4 million claim maintaining that the university owed it more money because the $42 million project was plagued with design flaws, change... - CDC Leads SSRI Disinformation Media Blitz
Jul-20-07 Washington, DC: In a June 27, 2007 press release that made headlines all over the world the US Centers for Disease Control announced that birth defects associated with the use of antidepressants by pregnant women are rare. As proof for this claim, the CDC cited two new studies published in the New England Journal of Medicine. Over the following 2 week... - IT Overtime Abuse
Jul-18-07 Tooele City, UT "When I was hired as a systems analyst in 1997, my boss said there wouldn't be any overtime ," says Andrew Rowley. "Just two weeks later, a manager said I would be fired if I didn't get my job done—I had to be on call 24/7." They called Rowley when he was shopping for groceries, at home with his kids, even in the middle of the nig... - Shelhigh Medical Devices agrees to FDA Terms - Part Two
Jul-18-07 Union, NJ At least two New Jersey hospitals indicated they had stopped using Shelhigh Medical Devices immediately after reports of the product seizures surfaced: Robert Wood Johnson University Hospital in New Brunswick NJ, and Hackensack University Medical Centre. (U.S. Marshals acting on behalf of the FDA seized all devices at Shelhigh's manufacturi... - Ketek: Justifying the Risks
Jul-17-07 Bridgewater, NJ For some reason, the US Food and Drug Administration (FDA) felt that the benefits of using Ketek outweighed the risks, even though those risks include liver failure and possible death. The FDA approved the drug to treat mild sinus infections - infections that usually clear up on their own in a few days. Ketek was approved even though t... - Ortho Evra Birth Control Patch: Injuries and Lawsuits
Jul-15-07 Washington, DC Hundreds of women who were seriously injured by the Ortho Evra birth control patch have filed lawsuits alleging the patch's makers are responsible for their pain. Many of the women suffered strokes and blood clots after using the patch for short time spans. At least two women died from blood clots that developed after using the patch. I... - FDA Internal Memo: Early "Black Box" Recommendation Ignored
Jul-14-07 Washington, DC A 2006 internal FDA memorandum suggests that the FDA recommended GlaxoSmithKline, the maker of Avandia , add a "black box" (the strongest warning) about congestive heart failure to the drug's label more than a year ago. As well, a warning about macular edema, which can lead to blindness, was also recommended. Even though the recommenda... - Trasylol Lawsuits Now Being Filed
Jul-14-07 Berkeley, CA As if patients facing heart bypass surgery did not already have enough to worry about, there is now a chance that Trasylol , a drug used to prevent blood loss, might actually increase their risk of kidney problems, heart attacks, and strokes. Patients who suffered serious injuries as a result of Trasylol are now filing lawsuits against the dr...